286 related articles for article (PubMed ID: 15108827)
1. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis.
Yildirim K; Erdal A; Karatay S; Melikoğlu MA; Uğur M; Senel K
South Med J; 2004 Apr; 97(4):350-3. PubMed ID: 15108827
[TBL] [Abstract][Full Text] [Related]
2. [Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].
Bobek D; Zagar I; Kovač-Durmiš K; Perić P; Ćurković B; Babić-Naglić Ð
Reumatizam; 2012; 59(1):5-10. PubMed ID: 25486721
[TBL] [Abstract][Full Text] [Related]
3. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
[TBL] [Abstract][Full Text] [Related]
4. Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index in Turkish patients with ankylosing spondylitis: relationship with disease activity and quality of life.
Zahiroglu Y; Ulus Y; Akyol Y; Tander B; Durmus D; Bilgici A; Kuru O
Int J Rheum Dis; 2014 Feb; 17(2):173-80. PubMed ID: 24576273
[TBL] [Abstract][Full Text] [Related]
5. [The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis].
Liu B; Guo CY; Liu WQ; Wu N; Xing Q
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):566-9. PubMed ID: 16194404
[TBL] [Abstract][Full Text] [Related]
6. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis.
Kaya T; Bal S; Gunaydin R
Rheumatol Int; 2007 Feb; 27(4):323-7. PubMed ID: 17021712
[TBL] [Abstract][Full Text] [Related]
8. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
9. The relationship between enthesitis indices and disease activity parameters in patients with ankylosing spondylitis.
Sivas F; Mermerci Başkan B; Erkol Inal E; Akbulut Aktekin L; Barça N; Ozoran K; Bodur H
Clin Rheumatol; 2009 Mar; 28(3):259-64. PubMed ID: 18953622
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid a as a useful indicator of disease activity in patients with ankylosing spondylitis.
Jung SY; Park MC; Park YB; Lee SK
Yonsei Med J; 2007 Apr; 48(2):218-24. PubMed ID: 17461519
[TBL] [Abstract][Full Text] [Related]
12. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
[TBL] [Abstract][Full Text] [Related]
13. [Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany].
Brandt J; Westhoff G; Rudwaleit M; Listing J; Zink A; Braun J; Sieper J
Z Rheumatol; 2003 Jun; 62(3):264-73. PubMed ID: 12827403
[TBL] [Abstract][Full Text] [Related]
14. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
[TBL] [Abstract][Full Text] [Related]
15. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
[TBL] [Abstract][Full Text] [Related]
16. Fatigue and correlation with disease-specific variables, spinal mobility measures, and health-related quality of life in ankylosing spondylitis.
Alkan BM; Fidan F; Erten Ş; Aksekili H; Alemdar A; Eroğlu E; Ardıçoğlu Ö; Tosun A
Mod Rheumatol; 2013 Nov; 23(6):1101-7. PubMed ID: 23224065
[TBL] [Abstract][Full Text] [Related]
17. [The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis].
Grazio S; Grubisić F; Nemcić T; Matijević V; Skala H
Reumatizam; 2009; 56(2):63-76. PubMed ID: 20429263
[TBL] [Abstract][Full Text] [Related]
18. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity.
Waldner A; Cronstedt H; Stenström CH
Scand J Rheumatol Suppl; 1999; 111():10-6. PubMed ID: 10503554
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between sleep quality and nocturnal pain in ankylosing spondylitis].
Zhang SL; Li Y; Zhu J; Huang ZF; Zhang JL; Huang F
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):970-2. PubMed ID: 23886256
[TBL] [Abstract][Full Text] [Related]
20. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.
Grazio S; Kusić Z; Cvijetić S; Grubišić F; Balenović A; Nemčić T; Matijević-Mikelić V; Punda M; Sieper J
Rheumatol Int; 2012 Sep; 32(9):2801-8. PubMed ID: 21858541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
